- Home
- GTBP vs ACON Comparison
GTBP vs ACON Comparison
Compare GTBP & ACON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GTBP
- ACON
- Stock Information
- Founded
- GTBP 1965
- ACON 2008
- Country
- GTBP United States
- ACON United States
- Employees
- GTBP N/A
- ACON N/A
- Industry
- GTBP Biotechnology: Pharmaceutical Preparations
- ACON Retail: Computer Software & Peripheral Equipment
- Sector
- GTBP Health Care
- ACON Technology
- Exchange
- GTBP Nasdaq
- ACON Nasdaq
- Market Cap
- GTBP 5.5M
- ACON 4.5M
- IPO Year
- GTBP N/A
- ACON 2022
- Fundamental
- Price
- GTBP $1.77
- ACON $7.40
- Analyst Decision
- GTBP Strong Buy
- ACON Buy
- Analyst Count
- GTBP 1
- ACON 2
- Target Price
- GTBP $11.00
- ACON $481.00
- AVG Volume (30 Days)
- GTBP 74.2K
- ACON 13.5K
- Earning Date
- GTBP 08-13-2025
- ACON 08-13-2025
- Dividend Yield
- GTBP N/A
- ACON N/A
- EPS Growth
- GTBP N/A
- ACON N/A
- EPS
- GTBP N/A
- ACON N/A
- Revenue
- GTBP N/A
- ACON $54,601.00
- Revenue This Year
- GTBP N/A
- ACON $145.39
- Revenue Next Year
- GTBP N/A
- ACON $145.45
- P/E Ratio
- GTBP N/A
- ACON N/A
- Revenue Growth
- GTBP N/A
- ACON N/A
- 52 Week Low
- GTBP $1.72
- ACON $6.20
- 52 Week High
- GTBP $4.10
- ACON $3,499.51
- Technical
- Relative Strength Index (RSI)
- GTBP 31.45
- ACON 50.28
- Support Level
- GTBP $2.01
- ACON $6.51
- Resistance Level
- GTBP $2.11
- ACON $7.99
- Average True Range (ATR)
- GTBP 0.14
- ACON 0.41
- MACD
- GTBP -0.01
- ACON -0.01
- Stochastic Oscillator
- GTBP 8.77
- ACON 60.22
About GTBP GT Biopharma Inc.
GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.
About ACON Aclarion Inc.
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.